Masaki Yasukawa

Overview

Best Publications

• Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice

  Fumihiko Ishikawa;Masaki Yasukawa;Bonnie Lyons;Shuro Yoshida

  1136
  Citations

• The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan

  Toru Takahashi;Ken Maeda;Tadaki Suzuki;Aki Ishido

  993
  Citations

• Nationwide survey of hemophagocytic lymphohistiocytosis in Japan.

  Eiichi Ishii;Shouichi Ohga;Shinsaku Imashuku;Masaki Yasukawa

  579
  Citations

• HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide.

  Hideki Ohminami;Masaki Yasukawa;Shigeru Fujita

  458
  Citations

• Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice.

  Leonard D. Shultz;Yoriko Saito;Yuho Najima;Satoshi Tanaka

  412
  Citations

• Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome

  M. Tohyama;K. Hashimoto;M. Yasukawa;H. Kimura

  371
  Citations

• Severe Hypersensitivity Syndrome Due to Sulfasalazine Associated With Reactivation of Human Herpesvirus 6

  Mikiko Tohyama;Yoko Yahata;Masaki Yasukawa;Reiko Inagi

  341
  Citations

• Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18.

  Masashi Kohno;Hitoshi Hasegawa;Atsushi Inoue;Masatake Muraoka

  280
  Citations

• Epstein–Barr virus-encoded poly(A)– RNA supports Burkitt’s lymphoma growth through interleukin-10 induction

  Norihiko Kitagawa;Miyuki Goto;Kimikazu Kurozumi;Seiji Maruo

  273
  Citations

• Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR.

  Sachiko Okamoto;Junichi Mineno;Hiroaki Ikeda;Hiroshi Fujiwara

  254
  Citations

• Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.

  M Yasukawa;J M Zarling

  209
  Citations

• A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy.

  Shoichi Iriguchi;Shoichi Iriguchi;Yutaka Yasui;Yohei Kawai;Yohei Kawai;Suguru Arima

  195
  Citations

• Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans.

  Masaki Yasukawa;Masaki Yasukawa;Hideki Ohminami;Hideki Ohminami;Junko Arai;Junko Arai;Yoshihito Kasahara;Yoshihito Kasahara

  189
  Citations

• Reinforce the antitumor activity of CD8+ T cells via glutamine restriction

  Shogo Nabe;Takeshi Yamada;Takeshi Yamada;Junpei Suzuki;Koji Toriyama

  184
  Citations

• HLA Class I Binding of HBZ Determines Outcome in HTLV-1 Infection

  Aidan MacNamara;Aileen Rowan;Silva Hilburn;Ulrich Kadolsky

  181
  Citations

• Safety and persistence of WT1-specific T-cell receptor gene−transduced lymphocytes in patients with AML and MDS

  Isao Tawara;Shinichi Kageyama;Yoshihiro Miyahara;Hiroshi Fujiwara

  181
  Citations

• Identification of human telomerase reverse transcriptase-derived peptides that induce HLA-A24-restricted antileukemia cytotoxic T lymphocytes.

  Junko Arai;Masaki Yasukawa;Hideki Ohminami;Miki Kakimoto

  171
  Citations

• Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions

  Eiichi Ishii;Ikuyo Ueda;Ryutaro Shirakawa;Ken Yamamoto

  167
  Citations

• Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues.

  Akihiro Tsuboi;Yoshihiro Oka;Keiko Udaka;Masaki Murakami

  164
  Citations

• Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy.

  Atsutaka Minagawa;Atsutaka Minagawa;Atsutaka Minagawa;Toshiaki Yoshikawa;Masaki Yasukawa;Akitsu Hotta

  163
  Citations

• Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis.

  Yoshihiro Oka;Akihiro Tsuboi;Masaki Murakami;Manabu Hirai

  161
  Citations

• Perforin gene mutations in adult-onset hemophagocytic lymphohistiocytosis.

  Koji Nagafuji;Atsushi Nonami;Takashi Kumano;Yoshikane Kikushige

  160
  Citations

• Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety

  Toshiki Ochi;Hiroshi Fujiwara;Sachiko Okamoto;Jun An

  159
  Citations